Cart
sales@molnova.com
Phenothiazine
CAS No. 92-84-2
Phenothiazine( Phenothiazine | NSC 2037 | NSC-2037 NSC2037 )
Catalog No. M16650 CAS No. 92-84-2
Phenothiazine is a dopamine-2 (D2) receptor antagonist therefore decreases the effect of dopamine in the brain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 38 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePhenothiazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhenothiazine is a dopamine-2 (D2) receptor antagonist therefore decreases the effect of dopamine in the brain.
-
DescriptionPhenothiazine is a dopamine-2 (D2) receptor antagonist therefore decreases the effect of dopamine in the brain.
-
In Vitro——
-
In Vivo——
-
SynonymsPhenothiazine | NSC 2037 | NSC-2037 NSC2037
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number92-84-2
-
Formula Weight199.27
-
Molecular FormulaC12H9NS
-
Purity>98% (HPLC)
-
SolubilityDMSO: 40 mg/mL (200.73 mM)
-
SMILESC12=CC=CC=C1NC3=C(C=CC=C3)S2
-
Chemical Name10H-Phenothiazine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pluta K, et al. Eur J Med Chem, 2011, 46(8), 3179-3189.
molnova catalog
related products
-
Aplindore Fumarate
Aplindore Fumarate (DAB-452) is a small molecule dopamine D2 receptor partial agonist.Aplindore Fumarate exhibits high affinity for dopamine D2 and D3 receptors, and low affinity for dopamine D4, 5-hydroxytryptophan (5-HT2), and α1-adrenergic receptors.
-
MPTP-Hydrochloride
MPTP (hydrochloride) is a prodrug to the neurotoxin MPP which causes permanent symptoms of Parkinson's disease.
-
DOPEXAMINE
Dopexamine is a dopaminergic agonistDopexamine hydrochloride has interesting vasodilator properties, with marked intrinsic agonist activity at beta-2 adrenoreceptors and a lesser agonist activity at dopaminergic receptors (DA1 and DA2).?
